The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state
- PMID: 35869523
- PMCID: PMC9305035
- DOI: 10.1186/s12954-022-00660-2
The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state
Abstract
Background: The impact of public health policies during the COVID-19 pandemic on people who inject drugs (PWID) has varied across regions. In other countries, recent research has shown that PWID access to harm reduction services, despite rapid adaptations, has been negatively impacted. Our study describes these impacts in a rural state.
Methods: We conducted semi-structured interviews with PWID, community partners, and healthcare providers in the rural state of Maine (USA). We explored how changes made during the pandemic impacted access to harm reduction services, including basic services (i.e., shelter), syringe service programs, safe drug supply, low barrier treatment, and peer support. Interviews were analyzed using the framework method to apply Penchansky's model of access, with Saurman's modification, which includes six dimensions of access-accessibility, availability, acceptability, affordability, accommodation, awareness.
Results: We interviewed thirty-six stakeholders (N = 9 community partners, N = 9 healthcare providers, N = 18 PWID). Policies such as mobile outreach expansion, mail delivery of equipment, and relaxed telemedicine regulations facilitated accessibility to syringe service programs and low barrier buprenorphine treatment. Public health policies, such as social distancing and screening policies, reduced contact, which subsequently reduced acceptability and awareness of many services. Elimination of the one-for-one needle exchange in some areas increased, acceptability (i.e., perception of service), and affordability for PWID. However, some areas actually began enforcing a one-for-one needle exchange policy, which reduced affordability, acceptability, and awareness of services.
Conclusions: Changes resulting from the COVID-19 pandemic have impacted all dimensions of access to harm reduction services among PWID. While some barriers to harm reduction services were unavoidable during the pandemic, we found that specific policy decisions mitigated service barriers, while other policies exacerbated them. Relaxing needle exchange policies were particularly helpful in facilitating access to harm reduction services by giving community organizations flexibility to adapt to the evolving needs of PWID. These results can inform policies and service delivery to optimally mitigate the negative impacts on PWID during, and beyond, the pandemic.
Keywords: Injection drug use; Marginalized and mobile populations; Social and economic issues.
© 2022. The Author(s).
Conflict of interest statement
The authors declare they have no competing interests.
Similar articles
-
Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in metropolitan Chicago.PLoS One. 2025 Jan 7;20(1):e0293238. doi: 10.1371/journal.pone.0293238. eCollection 2025. PLoS One. 2025. PMID: 39774394 Free PMC article.
-
The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.Harm Reduct J. 2023 Feb 2;20(1):12. doi: 10.1186/s12954-023-00742-9. Harm Reduct J. 2023. PMID: 36732773 Free PMC article.
-
"Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.Addict Sci Clin Pract. 2024 Feb 23;19(1):13. doi: 10.1186/s13722-024-00444-y. Addict Sci Clin Pract. 2024. PMID: 38395940 Free PMC article.
-
Health service utilisation and access for people who inject drugs during COVID-19.Drug Alcohol Rev. 2022 Sep;41(6):1304-1310. doi: 10.1111/dar.13456. Epub 2022 Mar 9. Drug Alcohol Rev. 2022. PMID: 35266229 Free PMC article. Review.
-
Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.Harm Reduct J. 2020 Dec 1;17(1):95. doi: 10.1186/s12954-020-00445-5. Harm Reduct J. 2020. PMID: 33261636 Free PMC article. Review.
Cited by
-
Key and evolving needs of service providers in women's harm reduction centers during the COVID-19 pandemic.Harm Reduct J. 2025 Apr 25;22(1):66. doi: 10.1186/s12954-025-01228-6. Harm Reduct J. 2025. PMID: 40281455 Free PMC article.
-
Assessing coronavirus disease 2019 pandemic impacts on the health of people who inject drugs using a novel data sharing model.AIDS. 2025 Mar 15;39(4):434-447. doi: 10.1097/QAD.0000000000004076. Epub 2024 Dec 23. AIDS. 2025. PMID: 39612241 Free PMC article.
-
Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in metropolitan Chicago.PLoS One. 2025 Jan 7;20(1):e0293238. doi: 10.1371/journal.pone.0293238. eCollection 2025. PLoS One. 2025. PMID: 39774394 Free PMC article.
-
Improving the Health of People Who Inject Drugs Through COVID-19-Related Policies.Public Health Rep. 2023 Nov-Dec;138(6):862-864. doi: 10.1177/00333549231192468. Epub 2023 Aug 23. Public Health Rep. 2023. PMID: 37610106 Free PMC article. No abstract available.
-
Frame Shift: Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections.Clin Infect Dis. 2024 Feb 17;78(2):e12-e26. doi: 10.1093/cid/ciad664. Clin Infect Dis. 2024. PMID: 38018174 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical